Tassilo Waldraff

Tassilo Waldraff has experience working in various technology companies. Their most recent position is as a Senior Director AI at Patient21, starting in 2023. From 2017 to 2022, they worked as the CTO and co-founder of CellmatiQ GmbH. Prior to this, they served as Technical Lead of Innovations at Solera Holdings, Inc. from 2013 to 2016 and as Development Program Manager DaaS at Audatex (Schweiz) GmbH from 2011 to 2013.

Tassilo Waldraff attended the University of Stuttgart from 2005 to 2010, where they earned a Dipl. Inf. in Computer Science. Tassilo also obtained a Diploma in computer science (M.Sc.) with a focus on Software Engineering & Architecture from the same university in 2010. In addition to their formal education, Waldraff has a certification as a Scrum Master, although details regarding when and where the certification was obtained are not provided.